Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Prostate Cancer

Clinical Trial at: Texas Oncology - Waco

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

6520 Horizon Circle
Waco, Texas 76712
P: (254) 755-4460

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Arlington

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

515 W Mayfield Rd, Suite 101
Arlington, Texas 76014
P: (817) 664-4400

More Details View Practice Page

Myelodysplastic Syndrome

Clinical Trial at: Texas Oncology - Austin

Pevonedistat-3001: A Phase 3, Randomized, Controlled, Open-label, Clinical Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Patients With Higher-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Low-Blast Acute Myelogenous Leukemia

  • Details

ClinicalTrials.gov ID: NCT03268954
Diagnosis Type: High Risk
USOR Number: 17153

  • Practice Details

6204 Balcones Drive
Austin, Texas 78731
P: (512) 427-9400

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Beaumont

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

690 N 14th Street
Beaumont, Texas 77702
P: (409) 899-7180

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Austin

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

901 W 38th Street, Suite 200
Austin, Texas 78705
P: (512) 421-4100

More Details View Practice Page

Melanoma

Clinical Trial at: Texas Oncology - Tyler

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies (516-001)

  • Details

ClinicalTrials.gov ID: NCT02219711
Diagnosis Type: NA
USOR Number: 17038

  • Practice Details

910 E Houston St, Suite 100
Tyler, Texas 75702
P: (903) 579-9800

More Details View Practice Page

GI Stromal Tumor (GIST)

Clinical Trial at: Texas Oncology - El Paso

An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

  • Details

ClinicalTrials.gov ID: NCT03465722
Diagnosis Type: NA
USOR Number: 18016

  • Practice Details

7848 Gateway East
El Paso, Texas 79915
P: (915) 599-1313

More Details View Practice Page

Leukemia

Clinical Trial at: Texas Oncology - Dallas

A phase 3b study in previously untreated Chronic Lymphocytic Leukemia (CLL) subjects, excluding those with the 17p deletion, to evaluate debulking regimens prior to initiating venetoclax combination therapy (M16-788)

  • Details

ClinicalTrials.gov ID: NCT03406156
Diagnosis Type: CLL
USOR Number: 17106

  • Practice Details

7777 Forest Lane, Suite D400
Dallas, Texas 75230
P: (972) 566-7790

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Dallas

A phase III, multicenter, randomized, double blind, placebo-controlled study evaluating the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) completely resected (R0) non-small cell lung cancer (NSCLC)(CACZ885T2301)

  • Details

ClinicalTrials.gov ID: NCT03447769
Diagnosis Type: NA
USOR Number: 17167

  • Practice Details

8196 Walnut Hill Lane, Suite 100
Dallas, Texas 75231
P: (214) 739-4175

More Details View Practice Page

Liver Cancer

Clinical Trial at: Texas Oncology - Dallas

Phase I/II pharmacokinetic multi-tumor study of subcutaneous formulation of nivolumab monotherapy (CA2098KX)

  • Details

ClinicalTrials.gov ID: NCT03656718
Diagnosis Type: NA
USOR Number: 18119

  • Practice Details

3410 Worth Street, Suite 400
Dallas, Texas 75246
P: (214) 370-1000

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Flower Mound

Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (2002)

  • Details

ClinicalTrials.gov ID: NCT03535740
Diagnosis Type: NSCLC
USOR Number: 18076

  • Practice Details

4370 Medical Arts Drive, Suite 100
Flower Mound, Texas 75028
P: (972) 537-4100

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Plano

A Randomized, Double-Blind, Phase III Study of Pembrolizumab versus Placebo in Combination with Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy for the Treatment of High-Risk Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK3475-KN756)

  • Details

ClinicalTrials.gov ID: NCT03725059
Diagnosis Type: NA
USOR Number: 17188

  • Practice Details

3705 West 15th Street
Plano, Texas 75075
P: (972) 867-3577

More Details View Practice Page

Renal Cancer

Clinical Trial at: Texas Oncology - Longview

Phase I/II pharmacokinetic multi-tumor study of subcutaneous formulation of nivolumab monotherapy (CA2098KX)

  • Details

ClinicalTrials.gov ID: NCT03656718
Diagnosis Type: NA
USOR Number: 18119

  • Practice Details

1300 North 4th Street
Longview, Texas 75601
P: (903) 757-2122

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Texas Oncology - Sherman

A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03597295
Diagnosis Type: NA
USOR Number: 18134

  • Practice Details

2800 Highway 75 North
Sherman, Texas 75090
P: (903) 868-4700

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Sugar Land

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

1350 First Colony Blvd
Sugar Land, Texas 77479
P: (281) 277-5200

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Beaumont

A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20) (SPI-POZ-202)

  • Details

ClinicalTrials.gov ID: NCT03318939
Diagnosis Type: NSCLC
USOR Number: 17143

  • Practice Details

690 N 14th Street
Beaumont, Texas 77702
P: (409) 899-7180

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - McAllen

Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (2002)

  • Details

ClinicalTrials.gov ID: NCT03535740
Diagnosis Type: NSCLC
USOR Number: 18076

  • Practice Details

1901 South 2nd Street
McAllen, Texas 78503
P: (956) 687-5150

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Austin

Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (2002)

  • Details

ClinicalTrials.gov ID: NCT03535740
Diagnosis Type: NSCLC
USOR Number: 18076

  • Practice Details

901 W 38th Street, Suite 200
Austin, Texas 78705
P: (512) 421-4100

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Tyler

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients With Advanced or Metastatic Urothelial Carcinoma (516-003)

  • Details

ClinicalTrials.gov ID: NCT03606174
Diagnosis Type: NA
USOR Number: 18033

  • Practice Details

910 E Houston St, Suite 100
Tyler, Texas 75702
P: (903) 579-9800

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Dallas

A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel plus a Reduced Dose of Capecitabine versus Capecitabine Alone in Patients with HER2 Negative, Hormone Receptor Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated with a Taxane (ODO-TE-B301)

  • Details

ClinicalTrials.gov ID: NCT03326674
Diagnosis Type: NA
USOR Number: 17009

  • Practice Details

3410 Worth Street, Suite 400
Dallas, Texas 75246
P: (214) 370-1000

More Details View Practice Page

Pages